This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Encorium Group, MDRNA: Early Volume Plays

NEW YORK ( TheStreet) -- Several stocks trading near $5 were poised to move on above-average volume during Monday's session.

Encorium Group (ENCO) was set to trade sharply lower Monday after the company said late Thursday that it is delaying the filing of its annual report as the company's independent registered accounting firm has not completed its audit of Encorium's financials. The stock closed Thursday at $2.26 and fell more than 11% in the after-market session. The 50-day average daily volume for Encorium is 247,000, according to the Nasdaq.

MDRNA (MRNA) jumped by 16 cents, or 13.5%, to $1.35 in the premarket session after the company announced a study effort with Pfizer (PFE) focusing on the evaluation of MDRNA's proprietary di-alkylated amino acids (DiLA2) platform and UsiRNA constructs for RNA interference (RNAi). Additional details of the collaboration were not disclosed. The 50-day average daily volume for MDRNA is 1.53 million.

Microvision (MVIS - Get Report) surged by 40 cents, or 13.3%, to $3.42 in the premarket session after the company said it has received an $8.5 million purchase order for new PicoP Laser Projection Display Engine. The 50-day average daily volume for Microvision is 881,000.

RegeneRx Biopharmaceuticals (RGN) may lose ground Monday after the company's annual report contained a going concern qualification notice. RegeneRx closed Thursday at 59 cents. The three-month average daily volume for RegeneRx is 83,000, according to Yahoo! Finance.

-- Written by Robert Holmes in Boston.

Check out all of Monday's high-volume, under-$5 stocks at the Dollar Store

Follow Robert Holmes on Twitter and become a fan of on Facebook.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
ENCO $0.00 0.00%
MRNA $0.18 0.00%
MVIS $2.61 0.00%
AAPL $93.99 0.00%
FB $102.01 0.00%


Chart of I:DJI
DOW 15,973.84 +313.66 2.00%
S&P 500 1,864.78 +35.70 1.95%
NASDAQ 4,337.5120 +70.6750 1.66%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs